EHS
EHS

Researchers identify LZTR1 as evolutionarily conserved component of RAS pathway



Mutations in RAS proteins initiate many of the most aggressive tumors, and the search for pharmacological inhibitors of these proteins has become a priority in the battle against cancer. Michail Steklov, Francesca Baietti, and colleagues from the Anna Sablina lab identified LZTR1 as an evolutionarily conserved component of the RAS pathway.

Source link

EHS
Back to top button